Integral Derivatives’s Walgreens Boots Alliance WBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-12,900
Closed -$937K 1027
2017
Q4
$937K Sell
12,900
-6,300
-33% -$444K 0.02% 505
2017
Q3
$1.48M Buy
+19,200
New +$1.54M 0.03% 385
2017
Q2
Sell
-3,300
Closed -$274K 1299
2017
Q1
$274K Sell
3,300
-6,600
-67% -$553K 0.01% 937
2016
Q4
$819K Buy
9,900
+3,100
+46% +$256K 0.02% 563
2016
Q3
$548K Sell
6,800
-400
-6% -$32.6K 0.01% 602
2016
Q2
$600K Buy
+7,200
New +$581K 0.01% 556
2016
Q1
Sell
-16,300
Closed -$1.39M 1125
2015
Q4
$1.39M Sell
16,300
-33,000
-67% -$2.8M 0.04% 364
2015
Q3
$4.1M Buy
49,300
+43,000
+683% +$3.89M 0.11% 147
2015
Q2
$532K Sell
6,300
-57,000
-90% -$4.91M 0.01% 700
2015
Q1
$5.36M Buy
63,300
+30,000
+90% +$2.39M 0.11% 106
2014
Q4
$2.54M Buy
33,300
+19,500
+141% +$1.3M 0.04% 359
2014
Q3
$818K Buy
+13,800
New +$905K 0.01% 797
2014
Q2
Sell
-61,300
Closed -$4.05M 1534
2014
Q1
$4.05M Sell
61,300
-45,500
-43% -$2.86M 0.08% 218
2013
Q4
$6.13M Buy
+106,800
New +$6.21M 0.08% 196

Other funds holding WBA

Integral Derivatives's WBA Position: Q4 2017 in Review

Integral Derivatives sold out of Walgreens Boots Alliance (WBA) in Q4 2017, closing a stake of 3,679 shares — an estimated $259K sold.

Integral Derivatives first reported a position in WBA in Q1 2014 and held it in 4 quarters. The position peaked at $2.78M in Q3 2015. 1,321 funds tracked by Wall St. Rank hold WBA as of Q4 2017.

  • Integral Derivatives reported no remaining Walgreens Boots Alliance position as of Q4 2017 after selling out during the quarter.
  • Integral Derivatives sold 3,679 Walgreens Boots Alliance shares in Q4 2017, an estimated $259K.
  • Integral Derivatives first reported a position in Walgreens Boots Alliance in Q1 2014 and held it in 4 quarters.
  • Integral Derivatives's Walgreens Boots Alliance position peaked at $2.78M in Q3 2015.
  • 1,321 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q4 2017.

Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.